Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich water improves sleep consolidation and enhances forebrain neuronal activation in mice

Vincent SM et al. · Sleep Adv. 2024;5(1):zpad057.

PreclinicalH₂-rich waterPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Pseudo-randomized within-animal sleep experiment plus separate controlled histology experiment

Research topic

Sleep and mood research

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Adult C57BL/6J mice under baseline and acute sleep-deprivation conditions

Sample

10 mice in the EEG/EMG crossover experiment; 33 additional mice in four histology groups

Duration

7 days per water condition, followed by 24-hour baseline recording, 6-hour sleep deprivation and 18-hour recovery

Intervention

Ad libitum hydrogen-rich water for 7 days, replaced every 2 hours during the active phase

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

H₂ specification

0.7–1.4 mM reported in the abstract; approximately 1–2 ppm maintained during the active phase.

H₂ flow

Not applicable — oral water in mice, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

Standard deionized water with matched cage disturbance; order counterbalanced in the polysomnography experiment

Reported, not endorsed

Outcomes and reported result

Outcomes measured

EEG/EMG sleep architecture, arousals, sleep latency, recovery NREM/REM sleep and cFos-positive cells in sleep-related brain regions

Reported result

H₂ water was associated with about 30% fewer brief arousals at baseline and more NREM and REM sleep after deprivation; several other fragmentation measures were not significantly different. Histology showed region-dependent cFos differences.

Results-extraction completeness

Full methods, results, funding and disclosures checked in the open-access article; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Mouse study, only 10 animals in the crossover sleep recording, multiple sleep features and separate histology cohorts. Tablets were supplied by HRW Natural Health Products; one author held a related patent and another disclosed consulting and speaking fees.

Applies directly to

Laboratory sleep and sleep-deprivation outcomes in mice; it does not establish treatment benefit for human insomnia.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 38264142 · DOI: 10.1093/sleepadvances/zpad057

Publisher access

Open-access full text is available through PMC and Oxford Academic.

Extraction basis

Open-access PMC and publisher full texts plus PubMed record.

Record revision

2026-08-10